O'NEIL PATRICK R. — SEC insider filings
SEC reporting owner CIK 1564926. 47 insider filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2020-09-02 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 32 legs across 25 filings — 332,104 shares, $19,965,548 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 72.
- Largest priced transaction: sale of 65,475 shares @ $60.89 ($3,986,773) in IONIS PHARMACEUTICALS INC, filed 2025-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC (IONS) | EVP CLO & General Counsel | 47 | — | 32 legs · 332,104 sh · $19,965,548 | 72 |
Insider filings — O'NEIL PATRICK R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 63 @ $51.31 | EDGAR |
| 2026-06-30 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 3,069 @ $80 | EDGAR |
| 2026-03-11 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,148 @ $75.25 | EDGAR |
| 2026-03-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 376 @ $48.87 | EDGAR |
| 2026-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,991 @ $0 · Sale (S): 6,179 @ $83.53 | EDGAR |
| 2026-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 21,473 @ $0 · Sale (S): 9,191 @ $75.84 · Grant/award (A): 25,800 (derivative) @ $0 · Option exercise (M): 21,473 (derivative) @ $0 · Grant/award (A): 9,675 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 19,350 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 10,200 @ $52.87 · Sale (S): 10,200 @ $69.89 · Sale (S): 3,241 @ $69.27 · Option exercise (M): 10,200 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 30,203 @ $56.78 · Sale (S): 30,203 @ $67.69 · Option exercise (M): 34,461 @ $60.89 · Sale (S): 34,461 @ $67.69 · Option exercise (M): 30,203 (derivative) @ $0 · Option exercise (M): 34,461 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 10,473 @ $56.78 · Sale (S): 10,473 @ $64.54 · Option exercise (M): 14,827 @ $56.78 · Sale (S): 14,827 @ $64.68 · Option exercise (M): 10,473 (derivative) @ $0 · Option exercise (M): 14,827 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,700 @ $56.78 · Sale (S): 1,700 @ $64.58 · Option exercise (M): 1,700 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 20,000 @ $60.89 · Sale (S): 20,000 @ $64.56 · Option exercise (M): 1,000 @ $56.78 · Sale (S): 1,000 @ $64.56 · Option exercise (M): 1,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 13,050 @ $32.60 · Sale (S): 13,050 @ $54.51 · Option exercise (M): 14,000 @ $37.58 · Sale (S): 65,475 @ $60.89 · Option exercise (M): 13,050 @ $32.60 · Sale (S): 11,375 @ $61.42 · +5 more | EDGAR |
| 2025-09-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 331 @ $27.71 | EDGAR |
| 2025-03-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 554 @ $28.21 | EDGAR |
| 2025-02-24 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,207 @ $32.35 | EDGAR |
| 2025-02-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 6,165 @ $31.62 | EDGAR |
| 2025-02-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 3,820 @ $0 · Sale (S): 1,406 @ $32.49 | EDGAR |
| 2025-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 19,690 @ $0 · Sale (S): 7,360 @ $32.83 · Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 33,000 (derivative) @ $0 · Option exercise (M): 19,690 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4/A | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,995 @ $49.67 | EDGAR |
| 2024-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 246 @ $38.64 | EDGAR |
| 2024-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 3,820 @ $0 · Sale (S): 1,961 @ $49.67 | EDGAR |
| 2024-01-29 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 6,450 @ $51.75 | EDGAR |
| 2024-01-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 20,641 @ $0 · Sale (S): 7,744 @ $50.42 · Option exercise (M): 20,641 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 17,000 (derivative) @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 27,200 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 20,825 @ $47.34 · Sale (S): 20,825 @ $51.46 · Option exercise (M): 20,825 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,527 @ $41.70 | EDGAR |
| 2023-03-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 301 @ $30.52 | EDGAR |
| 2023-02-07 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 3,822 @ $0 · Sale (S): 1,920 @ $40.86 | EDGAR |
| 2023-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 4,500 @ $39.42 · Sale (S): 4,500 @ $39.71 | EDGAR |
| 2023-01-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 21,871 @ $0 · Sale (S): 7,836 @ $39.49 · Option exercise (M): 21,871 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 14,338 (derivative) @ $0 · Grant/award (A): 17,207 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 22,942 (derivative) @ $0 | EDGAR |
| 2022-09-01 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 108 @ $28.97 | EDGAR |
| 2022-04-14 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 6,792 @ $40.06 | EDGAR |
| 2022-03-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 735 @ $28.37 | EDGAR |
| 2022-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 21,086 @ $0 · Tax withholding (F): 7,501 @ $30.12 · Option exercise (M): 21,086 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,463 (derivative) @ $0 · Grant/award (A): 15,284 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 30,567 (derivative) @ $0 | EDGAR |
| 2021-09-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 309 @ $33.80 | EDGAR |
| 2021-03-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 197 @ $44.54 | EDGAR |
| 2021-01-27 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 5,324 @ $63.50 | EDGAR |
| 2021-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 16,504 @ $0 · Tax withholding (F): 5,856 @ $61.28 · Grant/award (A): 25,868 (derivative) @ $0 · Option exercise (M): 16,504 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 58,203 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 169 @ $44.45 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1564926 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs